Drug Research
The rise and rise of Global Pharma Excipients Market
With the rise in the Global Pharma Industry, excipients too are bound to have their share of light. Of late, there has been an increasing demand for generic drugs which has, in turn, led to a rise of the...
Drug Research
Sygnature Discovery develops AR molecular visualisation prototype
The space occupied by a drug molecule in three dimensions, and how it fits into the target, is an important consideration when designing a new compound that might become a drug. Medicinal chemists commonly use 3D rendering software to...
Drug Research
Signant Health Brings Its eConsent Solution to China for Large Neuroscience Study in Collaboration with Shanghai Mental Health Center
Signant Health (formerly CRF Health and Bracket), a leading patient-centric technology company, has been selected to provide electronic informed consent for a significant neuroscience study by the prestigious Shanghai Mental Health Center (SMHC). This landmark investigator-led Schizophrenia trial, which...
Drug Research
Bora secures FDA approval for CDMO services
Bora, a contract development and manufacturing organization (CDMO) that specializes in modified release (MR) and solvent production, has reported a successful FDA general inspection for its facility in Zhunan, Taiwan.
The publicly listed company recently hosted the site’s fifth successful...
Articles
Particle analysis: Growing demand with biologics
The development and introduction of new biological drug substances has been on the rise, and so have the regulatory requirements placed on these often life-saving products. At the same time, innovative analytical technologies have been developed that offer new...
Drug Research
New calcium ingredient with improved flow and compactability properties
At this year’s CPhI Worldwide, mineral producer Omya will launch its new Calcipur® DC range, which comprises seven different grades of high-purity, directly compressible and free-flowing Natural Calcium Carbonates. Thanks to improved processing properties, the ingredient is ideally suited...
Drug Research
Cancer Research UK and Hummingbird Bioscience join forces to advance novel antibody drug into clinical trials
Cancer Research UK, the world’s leading cancer charity, and Hummingbird Bioscience, an innovative systems-biology enabled biotechnology company, have announced a partnership to develop Hummingbird’s anti-HER3 antibody drug, HMBD-001, for the treatment of people with HER3 driven cancer.
Under the terms...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
